PUBLISHED-SEQUENCE ANTIBODY · SC-PSA-0677

Lirilumab antibody

KIRD2

Available by inquiry

Lirilumab is a research antibody reference targeting KIRD2. Pure and fluorescently conjugated formats are available by inquiry.

Catalog number
SC-PSA-0677
Target
KIRD2
Available formats
Pure or fluorescently conjugated
Research use
For research use only

Product information

Available labeling options

Pure · Biotin · BV421 · V450 · V500 · AF488 · PerCP-Cy5.5 · PE · AF594 · PE-Cy5 · PE-Cy7 · APC · AF700 · APC-Cy7

Tell us the intended application, amount and preferred label. Final configuration and delivery are confirmed in the quotation.

PUBLIC REFERENCE

Reference source

WHO Recommended INN List 69 (2013)

View reference ↗
START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact us
Lirilumab Antibody (KIRD2) | StellaCyte